SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-144307
Filing Date
2014-04-15
Accepted
2014-04-15 17:00:34
Documents
7
Period of Report
2014-06-05
Effectiveness Date
2014-04-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d710903ddef14a.htm DEF 14A 317181
2 GRAPHIC g710903page_039a.jpg GRAPHIC 64235
3 GRAPHIC g710903page_039b.jpg GRAPHIC 64640
4 GRAPHIC g710903page_039c.jpg GRAPHIC 19021
5 GRAPHIC g710903page_039d.jpg GRAPHIC 30071
6 GRAPHIC g710903page_039e.jpg GRAPHIC 54848
7 GRAPHIC g710903page_040.jpg GRAPHIC 27994
  Complete submission text file 0001193125-14-144307.txt   678700
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 14765621
SIC: 2835 In Vitro & In Vivo Diagnostic Substances